On the Horizon – Phase III Trial of MDV3100 in Advanced Prostate Cancer Begins
Medivation, Inc. (MDVN) has formally begun its phase III trial of the investigational drug MDV3100 with men who have advanced prostate cancer. The clinical trial known as AFFIRM will evaluate the novel androgen receptor antagonist, [...]
Does ADT3 Work for Men with A Biochemical Prostate Cancer Recurrence?
One of the most heated debates in prostate cancer care is around the use of 5-reductase inhibitors (5ARI) like Dutasteride as a third component of a hormone blockade (ADT3). 5-ARIs block the conversion of testosterone [...]
Effects of Denosumab on Bone Mineral Density in Men Receiving ADT for Prostate Cancer
The relatively new drug, denosumab, has proven itself very effective for men on a hormone blockade (ADT). In a recently completed 3-year, randomized, double-blind study at the Massachusetts General Hospital Cancer Center, Boston, Massachusetts, denosumab [...]
Scott Goodwin Checks In
Scott Goodwin who periodically has been writing about his journey taking chemotherapy has given us a very moving update. Sadly, Scott is not doing well physically, but he is continuing his valiant fight against this [...]
Majority Of Unintended Incidents In The Emergency Room Are Caused By Human Error
A very scary study has been published in the journal BMC Emergency Medicine. The study found that sixty percent of the causes of unintended incidents in the emergency department that could have compromised patient safety [...]
A Provenge Trial That Is Currently Recruiting Participants
There is a provenge clinical trial which is currently recruiting participants. Remember, as with all trials, you must fit all of the criteria to participate. This trial does not use a placebo, you are guaranteed [...]